SUBSCRIBE: Print / eNewsletter
Top Gynecologic Cancer News of 2017
Could BEP Reduce the Risk of Brain Metastasis in Testicular Cancer?
A post-hoc analysis found that brain metastases are more frequent in patients with advanced germ cell tumors who have received dose-dense chemotherapy compared with those administered the BEP regimen.
Pretreatment Cognitive Impairment Is Common in Patients With Head and Neck Cancer
Results from a study of patients with newly diagnosed head and neck cancer indicate that cognitive screening should be incorporated into pretreatment assessment for patients in order to improve outcomes.
Tobacco Smoking Associated With Poor Survival Following Head and Neck Cancer Diagnosis
Researchers found a statistically significant difference in median survival time between smokers and nonsmokers at diagnosis of head and neck squamous cell carcinoma.
Shock-Waves Reduce Finger Ulcers in Scleroderma
Compared with conventional treatment, extracorporeal shock-wave therapy resulted in a significant decrease in finger ulcers.
Obesity Weighs on Spondyloarthropathy Outcomes
Patients experience higher disease activity, lower quality of life, and worse physical functioning.
Bone Marrow Swelling: Spondyloarthritis or Healthy Athlete?
MRI of the sacral spine may help determine which patients are in need of rheumatologic care.
Opioid Use for Osteoarthritis Is Prevalent
A large percentage of patients with advanced knee, hip, or spine OA take opioids for their chronic pain.
Juvenile Onset Arthritis Raises Pregnancy Risks
The risk of pregnancy-related complications is further increased when juvenile arthritis persists into adulthood.
Pembrolizumab Not Active Against Cisplatin-Refractory Testicular Cancer
In a small phase II study of 12 men with nonseminoma germ cell tumors refractory to cisplatin, pembrolizumab did not demonstrate clinical activity.